Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Our review examined recent evidence on asthma management, focusing on updated clinical guidelines, pharmacologic and non-pharmacologic treatment strategies, and population-specific considerations. Particular attention was given to the Global Initiative for Asthma and the National Heart, Lung, and Blood Institute guidelines.
Methods: We included peer-reviewed articles, clinical guidelines, systematic reviews, meta-analyses, randomized controlled trials, and cohort studies published in English from January 2018 to August 2024. Studies not focused on asthma management published before 2018 that were not in English or lacked relevant clinical content were excluded. Literature was identified via PubMed, Embase, Scopus, and the Cochrane Library searches. The GRADE framework assessed evidence quality across study design, consistency, and applicability. Due to heterogeneity in study designs and outcomes, a narrative synthesis was conducted.
Results: Sixty-two studies met inclusion criteria, including clinical guidelines ( = 4), systematic reviews/meta-analyses ( = 14), randomized controlled trials ( = 18), cohort studies ( = 11), and expert reviews ( = 15). These addressed pharmacologic therapy, biologics, digital health tools, and care in specific populations. High-certainty evidence supports inhaled corticosteroid-based stepwise therapy and biologics for severe asthma. Moderate-certainty evidence supports digital tools and lifestyle interventions, while alternative therapies have low-certainty support. Biologics like dupilumab and benralizumab showed consistent reductions in severe asthma exacerbations.
Discussion: Evidence was limited by heterogeneity, potential bias in lower-quality studies, and inconsistent outcome reporting. Findings affirm guideline-based therapy as foundational while highlighting the growing role of biologics and digital innovations.
Other: Our review received no external funding and was not registered in a systematic review registry.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12333720 | PMC |
| http://dx.doi.org/10.1097/MS9.0000000000003491 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Neurofilament Light Chain and Differentiation of Behavioral Variant Frontotemporal Dementia From Psychiatric Disorders: A Systematic Review.
JAMA Psychiatry
September 2025
Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville.
Importance: Behavioral variant frontotemporal dementia (bvFTD), the most common subtype of FTD, is a leading form of early-onset dementia worldwide. Accurate and timely diagnosis of bvFTD is frequently delayed due to symptoms overlapping with common psychiatric disorders, and interest has increased in identifying biomarkers that may aid in differentiating bvFTD from psychiatric disorders.
Objective: To summarize and critically review studies examining whether neurofilament light chain (NfL) in cerebrospinal fluid (CSF) or blood is a viable aid in the differential diagnosis of bvFTD vs psychiatric disorders.
From neglected to notoriety: a review of Mpox clinical features, virology, epidemiology, treatment and prevention strategies.
Eur J Clin Microbiol Infect Dis
September 2025
Department of Infectious and Tropical Diseases, Toulouse University Hospital, Toulouse, 31059 Cedex 9, France.
Purpose: This narrative review aims to provide an overview of current knowledge on mpox, emphasizing updated epidemiology and recent advances in treatment and prevention strategies, in light of the latest outbreaks.
Methods: We searched PubMed and Google Scholar for publications on 'Mpox' and 'Monkeypox' up to June 5, 2025. Grey literature from governmental and health agencies was also accessed for outbreak reports and guidelines where published evidence was unavailable.
Development of high-affinity peptide probes for improved diagnosis of Hashimoto's thyroiditis.
Mol Biol Rep
September 2025
Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Estimated fracture risk in osteopenic patients with primary hyperparathyroidism.
Endocrine
September 2025
Otorhinolaryngology, Head and Neck Surgery, Candiolo Cancer Institute, FPO-IRCCS Turin, Turin, Italy.
Background: While osteoporosis in primary hyperparathyroidism (PHPT) is widely studied, PHPT patients with osteopenia remain less characterized. This study aimed to evaluate the prevalence, biochemical features, and estimated fracture risk of osteopenic PHPT patients in a real-life cohort.
Methods: We retrospectively analyzed a consecutive series of PHPT patients with available densitometric data at three sites.
The timing of cryptorchidism surgery: analysis of the contradiction between guideline consensus and clinical practice implementation.
Pediatr Surg Int
September 2025
Department of Urology Children's Hospital, Chongqing Medical University, Room 806, Kejiao Building (NO.6), No.136, Zhongshan 2nd Road, Yuzhong District, Chongqing, 400014, China.
Cryptorchidism is one of the most common reproductive malformations in children, and the timing of surgery significantly impacts fertility and the risk of testicular cancer. Although international guidelines currently recommend testicular fixation within 6-18 months to improve prognosis, many children worldwide undergo surgery later than the recommended age. Delays in surgery are particularly significant in developing countries.
View Article and Find Full Text PDF